Press Release: Squire Patton Boggs appoints new life sciences leader

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Press Release: Squire Patton Boggs appoints new life sciences leader

Sponsored by

Squire Patton Boggs

Squire Patton Boggs selects Janice Rice to lead the life and health sciences patent team

(PALO ALTO/SAN FRANCISCO – December 16, 2019) – Squire Patton Boggs is pleased to announce the appointment of partner Janice Rice to Deputy Practice Group Leader of the Intellectual Property & Technology Practice Group, leading the life and health sciences patent team. Ms. Rice will succeed Cameron Kerrigan, who founded the practice. Mr. Kerrigan will continue to be a partner in the practice group in the Palo Alto and San Francisco offices.

“Cameron has been dedicated to the founding and growth of the group for almost 20 years. Without him, we would not have a globally recognized life and health sciences patent practice. We thank him for his hard work and leadership,” said David S. Elkins, global chair of the Intellectual Property & Technology Practice Group. “And we are very confident that Janice will successfully continue Cameron’s hard work. She has excelled in her practice, business development and acumen, and has the skills necessary to excel as Deputy Practice Group Leader.”

Ms. Rice has been a patent lawyer for more than 16 years in the California community. For more than 12 years of that time, she served as in-house patent counsel at small to mid-sized pharmaceutical companies. Before law school, Ms. Rice worked for nine years as a synthetic organic chemist. Using her knowledge of chemistry and law, Ms. Rice’s practice includes developing US and international patent strategies, patent drafting and prosecution, evaluation and protection of trade secrets, patentability and freedom to operate analyses, patent due diligence and advising on intellectual property licensing issues.

“I am extremely proud of the strength of the Squire Patton Boggs life sciences group, and in particular, our unwavering focus on providing strategic business advice and on quality service to our clients. It is an honor to be part of such a strong team,” said Ms. Rice.

Moving forward in the role, Ms. Rice plans to continue to strengthen the business development practices of the group, bring her corporate experience to continue to build a strong team atmosphere for colleagues around the globe, and to continue the firm’s commitment to foster the growth of each individual and encouragement of women in particular, to take risks and follow their intuition.

 

ENDS

more from across site and SHARED ros bottom lb

More from across our site

Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
On a recent trip to the French capital, we learned that the UPC is squeezing domestic litigation while firms are chasing senior talent, experimenting with AI and considering new ways of organising their practices
Daniel Law says a string of lateral hires and broader expansion plans will strengthen its position to capitalise on Brazil’s burgeoning IP and patent litigation market
Jason Raeburn’s arrival will expand the firm’s London footprint in AI, copyright and tech disputes
The firm is shaping its AI strategy around partnerships with Harvey and Legora alongside internally developed tools from its legal technology company, Eltemate
A dispute Down Under shows why trademark lawyers cannot afford to wait on the sidelines when a rival brand gathers momentum
The Third Circuit’s decision in Thomson Reuters v ROSS marks the first appellate-level decision addressing AI and fair use, prompting copyright counsel to consider arguments around potential licensing markets
Injunctions for HandsFree Labs and Align Technology come as the Court of Appeal warns that busy teams must have the staffing and resources to meet UPC deadlines
Gift this article